Company Encyclopedia
View More
name
Vident US Equity Strategy ETF
VUSE.US
News
View More

M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV

M Holdings Securities Inc. increased its holdings in AbbVie Inc. by 68.6% in Q2, owning 16,979 shares worth $3,121,000. Several other institutional investors also adjusted their positions in AbbVie. Analysts have upgraded AbbVie's stock ratings, with a current average rating of "Moderate Buy" and a target price of $241.85. AbbVie reported Q3 earnings of $1.86 EPS, beating estimates, and increased its quarterly dividend to $1.73 per share. The company has a market cap of $404.17 billion.

Market Beat·
US
ABBV
-0.66%
Market Beat·
US
ABBV
-0.66%

Meta opens a new frontier in AI race. Why it’s a warning for Apple.

Hassett eyed as Trump’s next Fed chair, Comcast’s cable spinoff could be valued at $10 billion, Hovnanian earnings sank the sector, more news to start your day.

MSN·
US
META
+3.43%
MSN·
US
META
+3.43%

Mirabella Financial Services LLP Has $2.41 Million Position in AbbVie Inc. $ABBV

Mirabella Financial Services LLP reduced its stake in AbbVie Inc. by 69.5% in Q2, owning 12,919 shares worth $2.41 million. Other institutional investors adjusted their positions in AbbVie. Analysts have varied ratings, with a consensus of "Moderate Buy" and a target price of $241.85. AbbVie reported Q3 earnings of $1.86 EPS, beating estimates, and increased its dividend to $1.73 per share. The stock opened at $228.68, with a market cap of $404.17 billion.

Market Beat·
US
ABBV
-0.66%
Market Beat·
US
ABBV
-0.66%

REG - JPMorgan Asset Mngt Bakkavor Group PLC - Form 8.3-Bakkavor Group plc

JPMorgan Asset Management has disclosed its public opening position in Bakkavor Group plc, as required by Rule 8.3 of the Takeover Code. The disclosure includes interests and short positions in relevant securities, with a total of 5,885,314 shares representing 1.02% of Bakkavor's ordinary shares. The disclosure also mentions dealings in cash-settled derivatives and confirms no indemnity or option arrangements. The disclosure is part of regulatory requirements under the Code, with further details available through the London Stock Exchange's RNS service.

London Stock Exchange·
US
JPM
+1.27%
London Stock Exchange·
US
JPM
+1.27%

Meta Platforms (NASDAQ:META) Upgraded by Arete Research to Strong-Buy Rating

Arete Research upgraded Meta Platforms (NASDAQ:META) from a "hold" to a "strong-buy" rating. Other analysts have also adjusted their price targets, with Rosenblatt Securities increasing theirs to $1,117.00 and Bank of America lowering theirs to $810.00. Meta's stock opened at $661.53, with a market cap of $1.67 trillion. Recent earnings exceeded expectations, and insider trading activity was noted. Institutional investors have been adjusting their positions in the company.

Market Beat·
US
META
+3.43%
Market Beat·
US
META
+3.43%
© 2025 Longbridge｜Disclaimer